Publications

Selected publications and reference material

BTS scientists have many years of experience in computational systems biology. Selected references for the different product areas and services are listed below.


2009200820072006200520042003


2009          -          

top of page

Willmann S, Edginton AN, Kleine-Besten M, Jantratid E, Thelen K, Dressman JB.
Whole-Body Physiologically-Based Pharmacokinetic Population Modelling of Oral Drug Administration: Inter-Individual Variability of Cimetidine Absorption.
J Pharm Pharmacol. 2009; 61, 891-899.

Thelen K, Dressman JB.
Cytochrome P450-mediated metabolism in the human gut wall.
J Pharm Pharmacol. 2009 May;61(5):541-58.

Edginton AN, Ahr G, Willmann S, Stass H.
Defining the Role of Macrophages in Local Moxifloxacin Tissue Concentrations using Biopsy Data and Whole-Body Physiologically Based Pharmacokinetic Modelling.
Clin Pharmacokinet. 2009; 48(3): 181-187.

Becker C, Dressman JB,  Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Barends DM.
Biowaiver monographs for immediate release solid oral dosage forms: Rifampicin.
J Pharm Sci. 2009 Jan 21. [Epub ahead of print]

Eissing T, Chaves M, Allgöwer F.
Live and let die—A systems biology view on cell death.
Comp Chem Eng. 2009; 33(3): 583-589.

Willmann S.
Das In-silico-Child. Können Computer-Simulationen klinisch-pharmakokinetische Studien ersetzten?
Pharm Unserer Zeit. 2009; 38(1): 62-67.


2008          -          

top of page

Edginton AN, Willmann S.
Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis.
Clin Pharmacokinet. 2008; 47(11): 743-752.

Edginton AN, Theil FP, Schmitt W, Willmann S.
Whole body physiologically-based pharmacokinetic models: their use in clinical drug development.

Expert Opin Drug Metab Toxicol. 2008;4(9): 1143-1152.

Loizou G, Spendiff M, Barton HA, Bessems J, Bois FY, d'Yvoire MB, Buist H, Clewell HJ 3rd, Meek B, Gundert-Remy U, Goerlitz G, Schmitt W.
Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps.
Regul Toxicol Pharmacol. 2008; 50(3):400-11.

Dressman JB, Thelen K, Jantratid E.
Towards Quantitative Prediction of Oral Drug Absorption.
Clin Pharmacokinet. 2008; 47(10): 655-67.

Becker C, Dressman JB, Amidon GL, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Barends DM.
Biowaiver monographs for immediate release solid oral dosage forms: Pyrazinamide.
J Pharm Sci. 2008; 97(9): 3709-20.

Granero GE, Longhi MR, Becker C, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Dressman JB, Barends DM.
Biowaiver monographs for immediate release solid oral dosage forms: Acetazolamide.
J Pharm Sci. 2008; 97(9): 3691-9.

Becker C, Dressman JB, Amidon GL, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Barends DM.
Biowaiver monographs for immediate release solid oral dosage forms: ethambutol dihydrochloride.
J Pharm Sci. 2008; 97(4): 1350-60.

Schmitt W.
General approach for the calculation of tissue to plasma partition coefficients.
Toxicol In Vitro. 2008; 22(2): 457-67.

Waldherr S, Eissing T, Allgöwer F.
Feedback during Life and Death of a Cell: Approaches for Systems Theoretical Analysis.
Automatisierungstechnik. 2008; 56(5): 233-240.

Chaves M, Eissing T, Allgöwer F.
Bistable biological systems: a characterization through local compact input-to-state stability.
IEEE Trans Aut Cont. 2008; 53(1): 87-100.


2007          -          

top of page

Willmann S, Höhn K, Edginton A, Sevestre M, Solodenko J, Weiss W, Lippert J, Schmitt W.
Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs.
J Pharmacokinet Pharmacodyn. 2007; 34(3): 401-431.

Vossen M, Sevestre M, Niederalt C, Jang IJ, Willmann S, Edginton AN.
Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models.
Theor Biol Med Model. 2007, 4: 13.

Willmann S, Edginton AN, Dressman JB.
Development and validation of a physiology-based model for the prediction of oral absorption in monkeys.
Pharm Res. 2007; 24(7): 1275-1282.

Kuepfer L, Peter M, Sauer U, Stelling J.
Ensemble modeling for analysis of cell signaling dynamics.
Nat Biotechnol. 2007; 25(9): 1001-1006.

Schuetz R, Kuepfer L, Sauer U.
Systematic evaluation of objective functions for predicting intracellular fluxes in Escherichia coli.
Mol Syst Biol. 2007; 3: 119.

Kuepfer L, Sauer U, Parrilo PA.
Efficient classification of complete parameter regions based on semidefinite programming.
BMC Bioinformatics. 2007; 8: 12.

Becker C, Dressman JB, Amidon GL, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Barends DM; International Pharmaceutical Federation, Groupe BCS.
Biowaiver monographs for immediate release solid oral dosage forms: isoniazid.
J Pharm Sci. 2007;96(3): 522-31.

Drasdo D, Hoehme S, Block M.
On the Role of Physics in the Growth and Pattern Formation of Multi-Cellular Systems: What can we Learn from Individual-Cell Based Models?
J Stat Phys. 2007; 128(1-2): 287-345.

Block M, Schöll E, Drasdo D.
Classifying the expansion kinetics and critical surface dynamics of growing cell populations.
Phys Rev Lett. 2007; 99(24): 248101.

Eissing T, Waldherr S, Allgöwer F, Scheurich P, Bullinger E.
Steady state and (bi-)stability evaluation of simple protease signalling networks.
BioSystems. 2007; 90(3): 591-601.

Eissing T, Waldherr S, Allgöwer F, Scheurich P, Bullinger E.
Response to Bistability in Apoptosis: Roles of Bax, Bcl-2, and Mitochondrial Permeability Transition Pores.
Biophys J. 2007; 92(9): 3332-3334.


2006          -          

top of page

Edginton AN, Schmitt W, Willmann S
Development and evaluation of a generic physiologically based pharmacokinetic model for children.
Clin Pharmacokinet. 2006; 45(10): 1013-1034.

Edginton AN, Schmitt W, Voith B, Willmann S
A mechanistic approach for the scaling of clearance in children.
Clin Pharmacokinet. 2006, 45(7): 683-704.
Erratum in: Clin Pharmacokinet. 2006; 45(11): 1075.

Edginton AN, Schmitt W, Willmann S
Application of physiology-based pharmacokinetic and pharmacodynamic modeling to individualized target-controlled propofol infusions.
Adv Ther. 2006; 23(1): 143-158.

Edginton AN, Willmann S
Physiology-based versus allometric scaling of clearance in children; an eliminating process based comparison.
Paediatr Perinat Drug Ther, 2006; 7 (3): 146-153.


2005          -          

top of page

Willmann S, Lippert J, Schmitt W.
From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools.
Expert Opin Drug Metab Toxicol. 2005; 1(1): 159-168.

Schmitt W, Willmann S
Physiology-based pharmacokinetic modeling: ready to be used.
Drug Discov Today. 2005; 2(1): 125-132.

Kuepfer L, Sauer U, Blank LM.
Metabolic functions of duplicate genes in Saccharomyces cerevisiae.
Genome Res. 2005; 15(10): 1421-1430.

Blank LM, Kuepfer L, Sauer U.
Large-scale 13C-flux analysis reveals mechanistic principles of metabolic network robustness to null mutations in yeast.
Genome Biol. 2005; 6(6): R49.

Eissing T, Allgöwer F, Bullinger E
Robustness properties of apoptosis models with respect to parameter variations and stochastic influences.
Syst Biol (Stevenage). 2005; 152(4): 221-228.


2004          -          

top of page

Willmann S, Schmitt W, Keldenich J, Lippert J, Dressman JB.
A physiological model for the estimation of the fraction dose absorbed in humans.
J Med Chem. 2004; 47(16): 4022-4031.

Eissing T, Conzelmann H, Gilles ED, Allgöwer F, Bullinger E, Scheurich P.
Bistability analyses of a caspase activation model for receptor-induced apoptosis.
J Biol Chem. 2004; 279(35): 36892-36897.


2003          -          

top of page

Willmann S, Schmitt W, Keldenich J, Dressman JB.
A physiologic model for simulating gastrointestinal flow and drug absorption in rats.
Pharm Res. 2003; 20(11): 1766-1771.

Willmann S, Lippert J, Sevestre M, Solodenko J, Fois F, Schmitt W
PK-Sim®: a physiologically based pharmacokinetic ‘whole-body’ model.
Biosilico. 2003; 1 (4): 121-124.

 

 

Quicksearch Quicksearch

April 23, 2009

New on-line services are now available!

» More

February 05, 2009

First milestone reached in research project on the predictive modeling of cancer therapies

» More

January 30, 2009

PK-Sim® Version 4.1 is now available!

» More

July 18, 2009

36th Annual Meeting and Exposition of the Controlled Release Society, Copenhagen, Denmark, July 18-22

» More

September 14, 2009

Bioinformatics Workshop at the Max Planck Institute for Molecular Genetics, Berlin, Germany, September 14

» More

October 04, 2009

American Conference on Pharmacometrics (ACoP), Mystic, CT, USA, October 4-7

» More